Check out our most popular compounded medications! Get Started
Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, Clonidine HCl. This is achieved through the use of Methocel E4M, a controlled-release polymer that ensures the gradual release of the medication over an extended period. This slow-release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance.
Clonidine HCl is primarily used in the treatment of hypertension, helping to lower high blood pressure and reduce the risk of strokes, heart attacks, and kidney problems. It is also used off-label for conditions such as withdrawal symptoms from opioids, nicotine, or alcohol, attention deficit hyperactivity disorder (ADHD), and certain pain conditions. The slow-release formulation of Clonidine HCl 430 µg Oral Capsules ensures a steady state of the medication in the body, providing consistent relief from these disease states.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules are a specialized formulation designed to provide a controlled and prolonged release of the active ingredient, Clonidine HCl. This formulation utilizes Methocel E4M, a type of controlled-release polymer, which allows for the gradual release of the medication over an extended period of time. This slow-release mechanism offers sustained therapeutic effects, reducing the need for frequent dosing and improving patient compliance, particularly beneficial for medications requiring a controlled release profile.
Clonidine HCl is a medication primarily used to treat high blood pressure, helping to prevent strokes, heart attacks, and kidney problems. It works by relaxing blood vessels so blood can flow more easily. In addition to hypertension, Clonidine HCl is also used to manage withdrawal symptoms from opioids and as part of ADHD treatment. It has a calming effect on certain parts of the brain, which makes it useful in treating psychiatric disorders. The slow-release formulation of Clonidine HCl 430 µg ensures a steady level of medication in the body, providing consistent therapeutic effects.
It is important for patients to understand that this medication should be taken exactly as prescribed by their healthcare provider. Abrupt discontinuation or rapid dosage reduction may lead to withdrawal symptoms such as nervousness, agitation, and headache, followed by a rapid rise in blood pressure. Therefore, when the decision has been made to discontinue treatment, the dosage should be decreased gradually.
For prescribers, it is crucial to note that the slow-release formulation of Clonidine HCl 430 µg may not be suitable for patients with certain medical conditions or for those taking certain medications. It is important to thoroughly review the patient's medical history and current medication regimen before prescribing this medication. Additionally, regular monitoring of blood pressure and adjustment of dosage may be necessary to achieve optimal therapeutic effects.
If you have any questions about Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to assist you.
Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules are formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to gradually release the encapsulated medication over an extended period of time. This slow release mechanism offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Clonidine is primarily used to treat high blood pressure, helping to prevent strokes, heart attacks, and kidney problems. It can also be used for withdrawal symptoms from opioids and as part of ADHD treatment. It works by relaxing blood vessels so blood can flow more easily and by affecting the levels of certain chemicals in your blood.
It's important to be aware of potential drug interactions with Clonidine. Certain medications can affect how Clonidine works or increase the risk of side effects. These include medications for depression, other high blood pressure drugs, heart medications, and certain psychiatric medications. It's crucial to inform your healthcare provider about all the medications you're currently taking, including prescription drugs, over-the-counter products, and herbal supplements.
Clonidine can also interact with alcohol and certain medications for anxiety or seizures, which can increase the risk of side effects like drowsiness, dizziness, and slow heart rate. It's recommended to avoid or limit the use of alcohol while being treated with Clonidine. Also, do not start, stop, or change the dosage of any medicines without your doctor's approval.
Clonidine should not be used with other high blood pressure medications unless specifically directed by your doctor, as it may increase the risk of side effects. It's also important to monitor your blood pressure regularly while taking this medication, as too low blood pressure can be dangerous.
Remember, this is not a complete list of possible drug interactions. Always consult with your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. If you have any questions about Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules, please reach out to us at Bayview Pharmacy. We are a team of knowledgeable compounding pharmacists ready to assist you.
The Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules are designed to provide a steady and controlled release of the active ingredient, Clonidine HCl, over an extended period of time. This is achieved through the use of Methocel E4M, a type of controlled-release polymer. Methocel E4M is a hydrophilic matrix system that swells upon contact with gastric fluids, creating a gel-like barrier that controls the rate at which the drug is released into the body. This slow and steady release of Clonidine HCl ensures a sustained therapeutic effect, reducing the need for frequent dosing and improving patient compliance.
Clonidine HCl is a medication that is primarily used to treat high blood pressure, helping to prevent strokes, heart attacks, and kidney problems. It works by relaxing blood vessels so that blood can flow more easily. In addition to its primary use, Clonidine HCl is also used to manage withdrawal symptoms from opioids and to treat certain behavioral disorders in children, among other off-label uses. The slow-release formulation of Clonidine HCl in these capsules allows for a steady state of the medication to be maintained in the body, providing consistent therapeutic effects.
It's important to note that while the slow-release formulation of Clonidine HCl provides many benefits, it may not be suitable for all patients. Some individuals may experience side effects such as dry mouth, constipation, and drowsiness. Additionally, it's crucial that patients do not stop taking this medication abruptly as it can cause a rapid increase in blood pressure. Therefore, it's essential for prescribers to monitor their patients closely and adjust the dosage as necessary to achieve the desired therapeutic effects while minimizing potential side effects.
If you have any questions about the Clonidine HCl 430 µg Slow Release (MEM4) Oral Capsules, or if you would like more information about how this formulation works, please don't hesitate to reach out to us at Bayview Pharmacy. Our team of knowledgeable compounding pharmacists is always here to help.
In addition to the aforementioned disease states that this formulation of Clonidine HCl 430 µG Slow Release (MEM4) Oral Capsules is commonly used for, it has multiple off-label applications as well. This drug is frequently utilized in the management of withdrawal symptoms associated with opioid, nicotine, or alcohol dependence. The slow-release properties of this formulation mean it provides a continuous layer of medication, thus helping to alleviate cravings and the physical manifestations of withdrawal over an extended period.
Clinically, Clonidine has been employed to manage hot flashes in menopausal women, offering an alternative for those who cannot or prefer not to use hormone replacement therapy. This use can be especially important given the enhanced compliance brought about by the reduced dosing frequency offered by this specific formulation. Furthermore, Clonidine has been explored for its potential uses in pediatric settings to assist in alleviating symptoms of attention deficit hyperactivity disorder (ADHD), particularly in instances where stimulant drugs are not preferred.
This particular Clonidine formulation has shown potential in managing conditions of dermatitis. Though not an FDA-approved use, some topical formulations of Clonidine can be used to relieve itchiness and inflammation associated with various forms of dermatitis. However, this warrants a case-by-case discussion with a healthcare provider.
It is important to note that this is not an exhaustive list of all the potential uses for Clonidine. Some physicians might prescribe it for other off-label uses depending on individual patient circumstances. It should be stressed that patients should not self-prescribe or adjust the dosage of this medication without medical consultation. This information serves to raise awareness of potential other uses for this formulation and should prompt further exploration with prescribers interested in these applications.
If you have further queries regarding the use, administration, or formulation of this or other custom-compounded medications, please feel free to reach out to us at Bayview Pharmacy. As seasoned compounding pharmacists, we're well-equipped to field your questions and concerns and would be happy to assist further. Please always consult with a healthcare provider before making changes to any medication regimen.
This is a medication that is formulated with Methocel E4M, a type of controlled-release polymer. It is designed to gradually release the encapsulated medication or active ingredient over an extended period of time.
The controlled-release formula provides sustained therapeutic effects which can improve patient compliance due to a reduced dosing frequency and a prolonged release profile.
Slow release refers to the manner in which the medication is released into the body. The encapsulated medication or active ingredient is designed to be released gradually over an extended period of time rather than all at once.
Yes, the slow release of the drug can increase its effectiveness by providing sustained therapeutic effects, facilitating better patient compliance and maintaining a constant drug concentration for a longer period of time.
Reduced dosing frequency simplifies medication schedules and can improve patient adherence, especially in those with chronic conditions who often require multiple medications.
Methocel E4M is a type of controlled-release polymer used for formulating medications, like this one, that require a controlled and prolonged release profile.
This medication should be taken orally, as directed by a healthcare provider. It's important not to break or chew the capsule so as not to disrupt the controlled-release system.
The drug is absorbed into the bloodstream through the digestive system after consumption. The Methocel E4M polymer allows for the controlled release of Clonidine in the body, maintaining a stable, therapeutic level over a longer period of time.
No, the capsule should not be opened, as doing so might interrupt the controlled-release profile of the drug.
This medication is suitable for patients who need sustained levels of Clonidine in their body over an extended period, as determined by their healthcare provider. Always consult your healthcare provider before starting any new medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
